EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs)

Florence O. McCarthy, Jean-Jacques Hélesbeux, Marc-Antoine Bazin, Tatiana Bernoussi, Justine Bonnet, Cédric Logé, Isabelle Ourliac-Garnier, Jean-Michel Robert, Mathieu Scaviner, Jérôme Thiéfaine, Thomas Yvorra, Vânia M. Moreira und 3 weitere

Drugs and Drug Candidates · 05.08.2026 · 5 (3) · 45

DOI: 10.3390/ddc5030045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 05.08.2026. Verfasst von Florence O. McCarthy und 14 weiteren Autor:innen. Die Arbeit nennt 324 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 33rd Annual Conference of the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), held in Nantes from 11 to 13 June 2025, marked a significant expansion of the organization’s scope and collaborative efforts. Building on the success of the previous meeting in Coimbra, the 2025 edition brought together 168 participants and featured a comprehensive scientific programme comprising 102 abstracts. A key highlight of this year’s conference was the collaboration with COST Action OneHealthdrugs and the Paul Ehrlich (PE) Euro-PhD Network, fostering interdisciplinary exchange and identifying future research synergies. The event included 1 computational workshop and 8 keynote lectures by international experts, alongside a strong emphasis on early-career researchers, with 25 oral presentations and 25 flash poster communications. In addition, 77 posters were presented across three dedicated sessions. All the presentations were eligible for 18 conference awards. Staying true to the GP2A and PE mission, the conference provided a dynamic platform for young scientists to engage with established researchers.

Zitieren

APA

McCarthy, F. O., Hélesbeux, J., Bazin, M., Bernoussi, T., Bonnet, J., Logé, C., Ourliac-Garnier, I., Robert, J., Scaviner, M., Thiéfaine, J., Yvorra, T., Moreira, V. M., Borges, F., Costi, M. P., & Marchand, P. (2026). 33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs). Drugs and Drug Candidates, 5(3), 45. https://doi.org/10.3390/ddc5030045

Vancouver

McCarthy FO, Hélesbeux J, Bazin M, Bernoussi T, Bonnet J, Logé C, et al. 33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs). Drugs and Drug Candidates. 2026;5(3):45. doi:10.3390/ddc5030045

BibTeX
@article{McCarthy2026,
  author = {McCarthy, Florence O. and Hélesbeux, Jean-Jacques and Bazin, Marc-Antoine and Bernoussi, Tatiana and Bonnet, Justine and Logé, Cédric and Ourliac-Garnier, Isabelle and Robert, Jean-Michel and Scaviner, Mathieu and Thiéfaine, Jérôme and Yvorra, Thomas and Moreira, Vânia M. and Borges, Fernanda and Costi, Maria Paola and Marchand, Pascal},
  title = {33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs)},
  journal = {Drugs and Drug Candidates},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {45},
  doi = {10.3390/ddc5030045}
}
Kostenlos starten →